Liposuction Complications: Severe Risks and Mortality Factors

Liposuction, while generally safe in qualified hands, carries rare but catastrophic complications. Understanding these risks informs patient selection, surgical technique, and informed consent.

Life-Threatening Complications

1. Fat Embolism Syndrome (FES)

• Mechanism: Intravascular fat globules → pulmonary microvasculature → V/Q mismatch, ARDS, cerebral embolism
• Incidence: 0.1-1% (clinical); higher with large-volume (>5L), ultrasonic/PAL, multiple areas
• Onset: 12-72 hrs post-op; hypoxia, confusion, petechiae (chest/conjunctiva), fever
• Mortality: 10-20% if fulminant

2. Pulmonary Embolism / DVT

• Immobility, venous injury, hypercoagulability (Virchow's triad)
• Prophylaxis: SCDs, early ambulation, chemoprophylaxis (enoxaparin) per Caprini

3. Lidocaine Toxicity (Tumescent Technique)

• Max safe dose: 35-55 mg/kg (with epinephrine)
• Signs: Tinnitus, perioral numbness, seizures, cardiovascular collapse
• Monitoring: Serial levels if >30 mg/kg used

4. Fluid Overload / Electrolyte Imbalance

• Large-volume tumescent infiltration → fluid shift
• Hyponatremia, hypervolemia → pulmonary edema, cerebral edema
• Strict I/O monitoring, replacement per formula

5. Sepsis / Necrotizing Fasciitis

• Contaminated infiltration, poor asepsis, immunocompromised
• Rapid progression; early broad-spectrum antibiotics, surgical debridement

Significant Morbidity

• Hemorrhage: >500 mL requires transfusion consideration
• Visceral perforation: Abdominal wall penetration → bowel injury
• Nerve injury: Sensory (numbness, dysesthesia) > motor; femoral, lateral cutaneous, intercostal
• Skin burns: Laser/UAL/PAL probe overheating
• Contour deformities: Over-resection, poor skin retraction → rippling, divots
• Seroma / Hematoma: Persistent → aspiration, sclerotherapy, reoperation
• Skin necrosis: Vascular compromise, infection, excessive superficial liposuction

Risk Mitigation

• Board-certified plastic surgeon (ABPS) in accredited facility
• Volume limits: <5L aspirate (outpatient); staged for large-volume
• Tumescent technique with epinephrine (vasoconstriction)
• Sequential compression, early ambulation, hydration
• Patient selection: BMI <30, no significant comorbidities, realistic expectations

Mortality estimated 1:5,000-1:10,000. Most deaths preventable with strict adherence to safety protocols.